Related Experiment Video
Updated: Nov 3, 2025
07:16
Author Spotlight: Advancements in DNA Nanosensors – Addressing Sensitivity and Selectivity Challenges in Molecular Detection
Published on: February 9, 2024
1.2K
DNA Nanotechnology-Based Biosensors and Therapeutics
Luyao Shen1,2, Pengfei Wang2, Yonggang Ke1
1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, 30322, USA.
Advanced Healthcare Materials
|June 4, 2021
Summary
DNA nanotechnology creates programmable nanostructures for biomedical uses. These DNA nanostructures offer precise targeting for biosensors and drug delivery in cancer therapy.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- DNA nanotechnology leverages Watson-Crick base pairing to create programmable nanostructures.
- These nanostructures exhibit precise engineering, programmability, and biocompatibility.
- They can interact with biological entities like molecules, nucleic acids, proteins, viruses, and cells.
Purpose of the Study:
- To review the development of DNA nanotechnology.
- To summarize recent applications in biosensors and therapeutics.
- To discuss challenges and opportunities for practical implementation.
Main Methods:
- Review of existing literature on DNA nanotechnology.
- Analysis of applications in biosensing.
- Analysis of applications in drug delivery and cancer therapy.
Main Results:
- DNA nanostructures are versatile tools for biomedical applications.
- Demonstrated utility in biosensors for detecting various targets.
- Effective as nanocarriers for therapeutic agent delivery, particularly in cancer therapy.
Conclusions:
- DNA nanotechnology holds significant promise for advancing biosensors and cancer therapeutics.
- Further research is needed to overcome challenges for widespread clinical adoption.
- The field presents numerous opportunities for innovation in personalized medicine.
